Homburger with Apellis on its financing

Homburger advised Apellis Pharmaceuticals on its senior secured USD 475 million financing on all swiss legal aspects of the transaction.

Homburger’s team

Daniel Haeberli (pictured) led Homburger’s team which further included Laura Müller, Yulia Shaburnykova (all financing) and Stefan Oesterhelt (tax).

Apellis Group

The Apellis group, centered around Apellis Pharmaceuticals, is a biopharmaceutical company specializing in the development and commercialization of therapeutic compounds aimed at treating a range of diseases. The group focuses on advancing innovative therapies targeting the complement system and is renowned for its work in ophthalmology and hematology.